Compare ELTX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | CBFV |
|---|---|---|
| Founded | 2011 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.4M | 174.1M |
| IPO Year | 2014 | 2014 |
| Metric | ELTX | CBFV |
|---|---|---|
| Price | $11.34 | $36.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $18.00 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 123.3K | 1.8K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.12% |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ 0.73 |
| Revenue | $2,301,000.00 | ★ $43,557,000.00 |
| Revenue This Year | N/A | $48.93 |
| Revenue Next Year | N/A | $7.97 |
| P/E Ratio | ★ N/A | $48.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.92 | $27.11 |
| 52 Week High | $14.93 | $37.75 |
| Indicator | ELTX | CBFV |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 59.26 |
| Support Level | $9.63 | $34.08 |
| Resistance Level | $11.47 | $36.44 |
| Average True Range (ATR) | 0.98 | 0.55 |
| MACD | 0.10 | 0.12 |
| Stochastic Oscillator | 59.84 | 100.00 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.